Bellicum Pharmaceuticals, Inc

CIK 1358403 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bellicum Pharmaceuticals, Inc.

Recent SEC filings

FiledFormAccession number
Aug 14, 2025SCHEDULE 13G0001172661-25-003569
Nov 14, 2024SC 13G/A0001172661-24-005309
Mar 1, 202415-12G0001539497-24-000604
Feb 26, 2024EFFECT9999999995-24-000535
Feb 26, 2024EFFECT9999999995-24-000536
Feb 26, 2024EFFECT9999999995-24-000539
Feb 26, 2024EFFECT9999999995-24-000537
Feb 26, 2024EFFECT9999999995-24-000534
Feb 26, 2024EFFECT9999999995-24-000533
Feb 23, 2024S-8 POS0001539497-24-000579
Feb 23, 2024S-8 POS0001539497-24-000576
Feb 23, 2024POS AM0001539497-24-000585
Feb 23, 2024S-8 POS0001539497-24-000567
Feb 23, 2024S-8 POS0001539497-24-000573
Feb 23, 2024S-8 POS0001539497-24-000569
Feb 23, 2024S-8 POS0001539497-24-000570
Feb 23, 20248-K0001539497-24-000590
Feb 23, 2024S-8 POS0001539497-24-000574
Feb 23, 2024POS AM0001539497-24-000581
Feb 23, 2024S-8 POS0001539497-24-000568
Feb 23, 2024S-8 POS0001539497-24-000578
Feb 23, 2024S-8 POS0001539497-24-000571
Feb 23, 2024S-8 POS0001539497-24-000572
Feb 23, 2024POS AM0001539497-24-000582
Feb 23, 2024POS AM0001539497-24-000580